my account
log out
|
|
my account
log out
|
Pexidartinib (PLX3397) |
| Create: 09/23/2019 |
| Expired Date: | never |
| Category: | Chemical |
| Message: | Pexidartinib (PLX3397) is an oral, potent mutil-targeted receptor tyrosine kinase inhibitor of CSF-1R with IC50 of 20 nM, Kit with IC50 of 10 nM, and Flt3 with IC50 160 nM. Phase 3, respectively.https://www.bocsci.com/pexidartinib-plx3397-cas-1029044-16-3-item-470807.html |
 | |
| City: | New York[US]
 |
| Location: |
|
| Sep 23 2019 |  | Y-27632 2HCl | 255 |
| Sep 23 2019 | | BMS-911543 | 271 |
| Sep 23 2019 | | JQ-1 cas 1268524-70-4 | 258 |
| Sep 23 2019 | | Alectinib | 250 |
| Sep 23 2019 | | Tubastatin A | 263 |
| Sep 23 2019 | | FLLL32 | 260 |
| Sep 23 2019 | | Thiazovivin | 264 |
| Sep 23 2019 | | Alpelisib | 266 |
| Sep 23 2019 | | Ribociclib | 242 |
| Sep 23 2019 | | Midostaurin | 240 |
| Copyright © toextrade Inc. All rights reserved. Contact us |